DR Congo records over 11,200 Ebola cases and 5,500 deaths, data show

Government data cited on 15 November show more than 11,200 cases and 5,500 deaths since the outbreak was announced on 15 May. Africa CDC chief Jean Kaseya says it remains uncontrolled.
In this article
More than 5,500 people have died and more than 11,200 Ebola cases have been recorded in the Democratic Republic of the Congo since the outbreak was announced on 15 May, government data cited on 15 November show. The death toll has risen from the more than 5,400 previously reported.
Jean Kaseya, director-general of the Africa Centres for Disease Control and Prevention (Africa CDC), told Reuters that the outbreak remained serious and uncontrolled, in an account published by Al Jazeera. He said more than 80% of new cases were emerging outside lists of people known to have had contact with an infected person, and over 65% of deaths had occurred in communities outside health centers.
The outbreak has affected 8 of DR Congo’s 26 provinces, and cases have also been reported in East, Central and West Africa, giving it the widest geographic spread of any Ebola outbreak on the continent to date. World Health Organization (WHO) director-general Tedros Adhanom Ghebreyesus said transmission was slowing in several early epicenters and clinical trials, including Tumaini and trials of new vaccine candidates, were advancing rapidly.
Delayed detection, conflict and strained health services have contributed to faster spread than in previous outbreaks. Al Jazeera reports that this is the second-largest and second-deadliest Ebola outbreak on record, behind the 2014–2016 West African epidemic, which infected more than 28,600 people and killed more than 11,000.
Funding and unpaid workers
Kaseya said donors had released only $1.3 billion of the $2.9 billion pledged for the response. He described coordination between DR Congo and donors as a “collective failure” and said Africa CDC was working with the government to prevent duplication and wasted funds.
DR Congo was also working to digitize the payroll for health workers who had not been paid for months, Kaseya said.
Vaccines and treatments under study
The outbreak is caused by Bundibugyo virus, which can cause hemorrhagic fever. The ongoing Tumaini trial is evaluating Ervebo against Bundibugyo; the vaccine’s effectiveness was established against a different Ebola virus, Zaire ebolavirus.
DR Congo’s Institut National de Recherche Biomédicale leads the trial with the University of Antwerp and other partners. The trial enrolls contacts of people with confirmed Bundibugyo disease in vaccination groups known as rings. WHO said 4 rings were already in place and more were being prepared.
WHO expert groups have recommended adding 2 vaccines designed for Bundibugyo: ChAdOx1, developed by the University of Oxford with the Serum Institute of India, and Moderna’s mRNA-1469. The recommendation for further clinical evaluation was based on available preclinical and early clinical evidence. They will enter the trial following national approvals.
The separate WHO-sponsored PARTNERS trial, launched in July, is evaluating whether the monoclonal antibody MBP134, the antiviral remdesivir or their combination can improve survival among patients with confirmed Bundibugyo disease. Maftivimab is also to be added as a potential treatment, while a complementary post-exposure prophylaxis study of obeldevisir is underway. WHO expects initial treatment-trial findings in the coming months and vaccine-trial results in early 2027.
Follow AveNews
HealthDR Congo Ebola outbreak kills more than 5,400
Health workers face shortages as the outbreak spreads across 8 provinces. A November 10 government tally recorded 11,042 confirmed cases, and a November 12 account put cumulative deaths above 5,400.
4 min
